nytimes.com/2013/04/26/busi... close friend in America who has PV and has now been treated with Gleevec for a while has, after his latest check up, been told by his endocrinologist, oncologist and haematologist that all his results are now essentially perfect and that he may well remain on Gleevec for 20+ years. At $100,000 per year this cold cost his insurers $2,000,000!
By coincidence that same day there was this article in the NY Times published April 25:
nytimes.com/2013/04/26/busi... addressing the extreme cost of drugs like Gleevec and asking whether the companies who make these drugs are in effect profiteering. This issue has also been raised in an open lettter from a number of doctors including specialist haematologists in the US like Dr Tefferi and Dr Silver.